1832 Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $968M | Buy |
1,969,618
+725,093
| +58% | +$394M | 0.89% | 23 |
|
|
2025
Q4 | $721M | Buy |
1,244,525
+4,211
| +0.3% | +$2.38M | 0.55% | 26 |
|
|
2025
Q3 | $602M | Buy |
1,240,314
+100,372
| +9% | +$46.7M | 0.47% | 27 |
|
|
2025
Q2 | $462M | Buy |
1,139,942
+351,167
| +45% | +$147M | 0.36% | 35 |
|
|
2025
Q1 | $392M | Buy |
788,775
+245,212
| +45% | +$133M | 0.36% | 37 |
|
|
2024
Q4 | $283M | Buy |
543,563
+32,751
| +6% | +$18M | 0.24% | 51 |
|
|
2024
Q3 | $316M | Sell |
510,812
-56,961
| -10% | -$33.7M | 0.24% | 45 |
|
|
2024
Q2 | $314M | Sell |
567,773
-345,497
| -38% | -$198M | 0.26% | 45 |
|
|
2024
Q1 | $531M | Sell |
913,270
-581,432
| -39% | -$326M | 0.31% | 23 |
|
|
2023
Q4 | $793M | Buy |
1,494,702
+73,089
| +5% | +$35.4M | 1.14% | 13 |
|
|
2023
Q3 | $720M | Buy |
1,421,613
+168,048
| +13% | +$89.5M | 1.02% | 14 |
|
|
2023
Q2 | $654M | Buy |
1,253,565
+215
| +0% | +$116K | 0.78% | 17 |
|
|
2023
Q1 | $722M | Buy |
1,253,350
+26,210
| +2% | +$14.8M | 1.05% | 14 |
|
|
2022
Q4 | $676M | Buy |
1,227,140
+189,187
| +18% | +$100M | 1.12% | 15 |
|
|
2022
Q3 | $526M | Sell |
1,037,953
-4,675
| -0.4% | -$2.62M | 0.98% | 22 |
|
|
2022
Q2 | $566M | Buy |
1,042,628
+180,533
| +21% | +$99.4M | 0.99% | 21 |
|
|
2022
Q1 | $502M | Buy |
862,095
+165,450
| +24% | +$95M | 0.71% | 35 |
|
|
2021
Q4 | $467M | Buy |
696,645
+68,925
| +11% | +$43M | 0.83% | 35 |
|
|
2021
Q3 | $366M | Sell |
627,720
-82,329
| -12% | -$45.2M | 0.69% | 47 |
|
|
2021
Q2 | $360M | Sell |
710,049
-29,496
| -4% | -$13.9M | 0.7% | 41 |
|
|
2021
Q1 | $335M | Buy |
739,545
+159,576
| +28% | +$76.2M | 0.72% | 43 |
|
|
2020
Q4 | $268M | Sell |
579,969
-180,161
| -24% | -$84.5M | 0.63% | 49 |
|
|
2020
Q3 | $332M | Buy |
760,130
+184,380
| +32% | +$76.2M | 0.87% | 35 |
|
|
2020
Q2 | $203M | Buy |
575,750
+290,633
| +102% | +$97.4M | 0.61% | 48 |
|
|
2020
Q1 | $81.7M | Buy |
285,117
+4,215
| +2% | +$1.33M | 0.29% | 84 |
|
|
2019
Q4 | $91.7M | Buy |
280,902
+202,603
| +259% | +$61.4M | 0.28% | 83 |
|
|
2019
Q3 | $22.3M | Sell |
78,299
-555,604
| -88% | -$159M | 0.07% | 177 |
|
|
2019
Q2 | $186M | Sell |
633,903
-164,140
| -21% | -$45.2M | 0.6% | 44 |
|
|
2019
Q1 | $217M | Buy |
798,043
+25,413
| +3% | +$6.32M | 0.74% | 38 |
|
|
2018
Q4 | $173M | Buy |
772,630
+179,210
| +30% | +$42M | 0.68% | 39 |
|
|
2018
Q3 | $145M | Buy |
593,420
+155,620
| +36% | +$35.8M | 0.47% | 64 |
|
|
2018
Q2 | $90.7M | Buy |
437,800
+130,534
| +42% | +$27.7M | 0.31% | 76 |
|
|
2018
Q1 | $63.6M | Buy |
307,266
+225,203
| +274% | +$47.3M | 0.23% | 102 |
|
|
2017
Q4 | $15.5M | Sell |
82,063
-444,549
| -84% | -$85.2M | 0.05% | 204 |
|
|
2017
Q3 | $96.6M | Buy |
526,612
+496,816
| +1,667% | +$90M | 0.34% | 73 |
|
|
2017
Q2 | $5.21M | Sell |
29,796
-13,937
| -32% | -$2.34M | 0.02% | 304 |
|
|
2017
Q1 | $6.73M | Sell |
43,733
-888,875
| -95% | -$136M | 0.02% | 296 |
|
|
2016
Q4 | $141M | Buy |
932,608
+232,529
| +33% | +$34.3M | 0.24% | 101 |
|
|
2016
Q3 | $111M | Buy |
700,079
+371,083
| +113% | +$57.2M | 0.42% | 60 |
|
|
2016
Q2 | $48.9M | Buy |
328,996
+247,514
| +304% | +$36.5M | 0.19% | 117 |
|
|
2016
Q1 | $19.1M | Sell |
81,482
-340,267
| -81% | -$45.6M | 0.05% | 244 |
|
|
2015
Q4 | $60.4M | Buy |
421,749
+25,939
| +7% | +$3.46M | 0.26% | 97 |
|
|
2015
Q3 | $48.5M | Sell |
395,810
-26,145
| -6% | -$3.41M | 0.2% | 108 |
|
|
2015
Q2 | $54.6M | Sell |
421,955
-391,850
| -48% | -$51.1M | 0.19% | 120 |
|
|
2015
Q1 | $109M | Sell |
813,805
-207,935
| -20% | -$26.8M | 0.41% | 68 |
|
|
2014
Q4 | $128M | Buy |
1,021,740
+88,987
| +10% | +$10.8M | 0.4% | 70 |
|
|
2014
Q3 | $113M | Buy |
932,753
+358,021
| +62% | +$43.5M | 0.37% | 71 |
|
|
2014
Q2 | $67.9M | Sell |
574,732
-647,978
| -53% | -$76.3M | 0.21% | 121 |
|
|
2014
Q1 | $145M | Buy |
1,222,710
+132,910
| +12% | +$15.8M | 0.5% | 55 |
|
|
2013
Q4 | $121M | Sell |
1,089,800
-216,960
| -17% | -$21.6M | 0.47% | 54 |
|
|
2013
Q3 | $120M | Sell |
1,306,760
-62,370
| -5% | -$5.64M | 0.53% | 55 |
|
|
2013
Q2 | $116M | Buy |
+1,369,130
| New | +$114M | 0.51% | 52 |
|
Other funds holding TMO
VCM
1832 Asset Management's TMO Position: Q1 2026 in Review
1832 Asset Management increased its Thermo Fisher Scientific (TMO) stake by 58% in Q1 2026, buying an estimated $394M and bringing the position to 1,969,618 shares worth $968M. The position accounts for 0.89% of the portfolio, ranked #23.
1832 Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- 1832 Asset Management held 1,969,618 shares of Thermo Fisher Scientific worth $968M as of Q1 2026.
- 1832 Asset Management bought 725,093 Thermo Fisher Scientific shares in Q1 2026, an estimated $394M.
- Thermo Fisher Scientific made up 0.89% of 1832 Asset Management's portfolio in Q1 2026, its #23 holding.
- 1832 Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.